Differential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarker

被引：0
|
作者：
Yong Gil Hwang
Goundappa K. Balasubramani
Ilinca D. Metes
Marc C. Levesque
S. Louis Bridges
Larry W. Moreland
机构：
[1] University of Pittsburgh,Department of Medicine, Division of Rheumatology and Clinical Immunology
[2] University of Pittsburgh,Department of Epidemiology, School of Public Health
[3] University of Alabama at Birmingham,Department of Medicine, Division of Clinical Immunology and Rheumatology Birmingham
[4] AbbVie Inc,undefined
来源：
Arthritis Research & Therapy | / 18卷
关键词：
Serum amyloid A; C-reactive protein; Early rheumatoid arthritis; Etanercept;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 28 条
  • [21] The value of serum type II collagen epitope measurement in assessing early clinical response to treatment with anti-tumour necrosis factor alpha therapy in rheumatoid arthritis
    Mullan, R. H.
    Lobanok, T.
    Walsh, C.
    King, L.
    FitzGerald, O.
    Bresnihan, B.
    Fearon, U.
    Poole, R.
    Veale, D. J.
    ARTHRITIS RESEARCH & THERAPY, 2005, 7 (Suppl 1) : S24 - S25
  • [22] The value of serum type II collagen epitope measurement in assessing early clinical response to treatment with anti-tumour necrosis factor alpha therapy in rheumatoid arthritis
    RH Mullan
    T Lobanok
    C Walsh
    L King
    O FitzGerald
    B Bresnihan
    U Fearon
    R Poole
    DJ Veale
    Arthritis Research & Therapy, 7
  • [23] Higher expression of TNFα-induced genes in the synovium of patients with early rheumatoid arthritis correlates with disease activity, and predicts absence of response to first line therapy
    De Groof, Aurelie
    Ducreux, Julie
    Humby, Frances
    Toukap, Adrien Nzeusseu
    Badot, Valerie
    Pitzalis, Costantino
    Houssiau, Frederic A.
    Durez, Patrick
    Lauwerys, Bernard R.
    ARTHRITIS RESEARCH & THERAPY, 2016, 18
  • [24] Higher expression of TNFα-induced genes in the synovium of patients with early rheumatoid arthritis correlates with disease activity, and predicts absence of response to first line therapy
    Aurélie De Groof
    Julie Ducreux
    Frances Humby
    Adrien Nzeusseu Toukap
    Valérie Badot
    Costantino Pitzalis
    Frédéric A. Houssiau
    Patrick Durez
    Bernard R. Lauwerys
    Arthritis Research & Therapy, 18
  • [25] Predictors of disease activity and structural progression after treatment with adalimumab plus methotrexate or continued methotrexate monotherapy in patients with early rheumatoid arthritis and suboptimal response to methotrexate
    Smolen, Josef S.
    van Vollenhoven, Ronald F.
    Florentinus, Stefan
    Chen, Su
    Suboticki, Jessica L.
    Kavanaugh, Arthur
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (11) : 1566 - 1572
  • [26] Predicting low disease activity and remission using early treatment response to antitumour necrosis factor therapy in patients with rheumatoid arthritis: exploratory analyses from the TEMPO trial
    Curtis, Jeffrey R.
    Yang, Shuo
    Chen, Lang
    Park, Grace S.
    Bitman, Bojena
    Wang, Brian
    Navarro-Millan, Iris
    Kavanaugh, Arthur
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (02) : 206 - 212
  • [27] Response to: "Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients" by Fornaro et al
    Agca, Rabia
    Heslinga, Sjoerd C.
    Rollefstad, S.
    Heslinga, S.
    Sodergren, Anna
    Semb, A. G.
    Kitas, George D.
    Sattar, Naveed
    Nurmohamed, Michael T.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (09)
  • [28] Response to 'Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomized study over 21 months'
    Miguel A Gonzalez-Gay
    Carlos Gonzalez-Juanatey
    Jose A Miranda-Filloy
    Javier Martin
    Maria T Garcia-Unzueta
    Javier Llorca
    Arthritis Research & Therapy, 13
123